The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Walker, Jennifer ^a   Fairley, Christopher K ^a,b   Bradshaw, Catriona S ^b,c   Tabrizi, Sepehr N ^d   Chen, Marcus Y ^a,b   Twin, Jimmy ^d   Taylor, Nicole ^d   Donovan, Basil ^e   Kaldor, John K ^e   McNamee, Kathleen ^f,g   Urban, Eve ^a   Walker, Sandra ^a   Currie, Marian ^h   Birden, Hudson ⁱ   Bowden, Francis ^h   Gunn, Jane ^a   Pirotta, Marie ^a   Gurrin, Lyle ^a   Harindra, Veerakathy ^j   Garland, Suzanne ^a,d   Hocking, Jane S ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Family Planning Victoria   (Australia)

^g MONASH MEDICAL CENTRE   (Australia)

^h AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j ST MARY S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MOXIFLOXACIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BACTERIAL LOAD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; GENITAL TRACT INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYCOPLASMA GENITALIUM; MYCOPLASMA GENITALIUM INFECTION; MYCOPLASMOSIS; PREVALENCE; SEROTYPE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UNSAFE SEX; VAGINA SMEAR; CROSS-SECTIONAL STUDY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SEXUALITY;

ADOLESCENT; ADULT; AUSTRALIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PREVALENCE; SEXUAL PARTNERS; VAGINAL SMEARS; YOUNG ADULT;

EID: 79351468976     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-35     Document Type: Article

References (47)

1. Department of Health and Ageing National Notifiable Diseases Surveillance System. 2009, Canberra: Commonwealth of Australia, Department of Health and Ageing.
2. Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M. A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sexual Health 2006, 3(4):235-240. 10.1071/SH06033, 17112433.
3. Kong F, Hocking JS, Link CK, Chen MY, Hellard ME. Sex and sport: chlamydia screening in rural sporting clubs. BMC Infectious Diseases 2009, 9(1):73. 10.1186/1471-2334-9-73, 2695469, 19470183.
4. Hocking JS, Walker J, Regan D, Chen MY, Fairley CK. Chlamydia screening-Australia should strive to achieve what others have not. Medical Journal of Australia 2008, 188(2):106.
5. Jensen J, Orsum R, Dohn B, Uldum S, Worm A, Lind K. Mycoplasma genitalium: a cause of male urethritis?. Genitourinary Medicine 1993, 69(4):265-269. 1195084, 7721285.
6. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, Sinei SK, Bwayo JJ, Totten PA. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002, 359(9308):765-766. 10.1016/S0140-6736(02)07848-0, 11888591.
7. Clausen H, Fedder J, Drasbek M, Nielsen P, Toft B, Ingerslev H, Birkelund S, Christiansen G. Serological investigation of Mycoplasma genitalium in infertile women. Human Reproduction 2001, 16(9):1866-1874. 10.1093/humrep/16.9.1866, 11527890.
8. Mavedzenge N. Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS 2009, 23(5):611. 10.1097/QAD.0b013e328323da3e, 19194271.
9. Manhart LE, Holmes KK, Hughes JP, Houston LS, Totten PA. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. American Journal of Public Health 2007, 97(6):1118-1125. 10.2105/AJPH.2005.074062, 1874220, 17463380.
10. Andersen B, Sokolowski I, Østergaard L, Møller JK, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sexually Transmitted Infections 2007, 83(3):237-241. 10.1136/sti.2006.022970, 2659104, 17090566.
11. Hay PE, Oakeshott P, Kerry S, Aghaizu A, Atherton H, Taylor-Robinson D, Simms I, Reid F, JS J. Is Mycoplasma genitalium in women "the new chlamydia"? Community based prevalence and prospective cohort study. ISSTDR: 2009. London UK 2009,
12. Carlsen KH, Jensen JS. Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity?. Journal of Clinical Microbiology 2010, 48(10):3624-3627. 10.1128/JCM.00232-10, 20720022.
13. Walker J, Fairley CK, Urban E, Chen MY, Bradshaw CS, Walker S, Donovan B, Tabrizi S, McNamee K, Currie M, et al. Methods for maximising retention in a longitudinal study of young women: an Australian prospective cohort. ISSTDR. London, U.K 2009,
14. Yoshida T, Deguchi T, Ito M, Maeda S, Tamaki M, Ishiko H. Quantitative detection of Mycoplasma genitalium from first-pass urine of men with urethritis and asymptomatic men by real-time PCR. Journal of Clinical Microbiology 2002, 40(4):1451-1455. 10.1128/JCM.40.4.1451-1455.2002, 140368, 11923372.
15. Resnick R, Cornelissen M, Wright D, Eichinger G, Fox H, Schegget J, Manos M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. JNCI Journal of the National Cancer Institute 1990, 82(18):1477.
16. Jensen JS, Uldum SA, Sondergard-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. Journal of Clinical Microbiology 1991, 29(1):46-50. 269700, 1993766.
17. Jensen JS, Bjornelius E, Dohn B, Lidbrink P. Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. Journal of Clinical Microbiology 2004, 42(2):683-692. 10.1128/JCM.42.2.683-692.2004, 344445, 14766837.
18. Twin J, Taylor N, Garland SM, Hocking JS, Walker J, Bradshaw CS, Fairley CK, Tabrizi SN. A comparison of two Mycoplasma genitalium real-time polymerase chain reaction detection methodologies. Journal of Clinical Microbiology 2011, JCM.02328-02310.
19. Stevens MP, Twin J, Fairley CK, Donovan B, Tan SE, Yu J, Garland SM, Tabrizi SN. Development and Evaluation of an ompA Quantitative Real-Time PCR Assay for Chlamydia trachomatis Serovar Determination. Journal of Clinical Microbiology 2010, 48(6):2060. 10.1128/JCM.02308-09, 2884500, 20392903.
20. Stevens MP, Tabrizi SN, Muller R, Krause V, Garland SM. Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. Journal of Clinical Microbiology 2004, 42(6):2501. 10.1128/JCM.42.6.2501-2507.2004, 427869, 15184427.
21. Edberg A, Jurstrand M, Johansson E, Wikander E, Hoog A, Ahlqvist T, Falk L, Jensen JS, Fredlund H. A comparative study of three different PCR assays for detection of Mycoplasma genitalium in urogenital specimens from men and women. Journal of Medical Microbiology 2008, 57(3):304. 10.1099/jmm.0.47498-0, 18287292.
22. Australasian College of Sexual Health Physicians Clinical guidelines for the management of sexually transmissible infections among priority populations. Accessed 2005 [online], Australasian College of Sexual Health Physicians., http://www.ashm.org.au
23. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clinical Infectious Diseases 2009, 48(12). 10.1086/599033, 19438399.
24. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008, 3(11). 10.1371/journal.pone.0003618, 2572837, 18978939.
25. Stata Corporation Stata Statistical Software: Release 10.2. 2007, College Station, TX: StatCorp, 10.0, Stata Corporation.
26. Australian Bureau of Statistics Census 2006. 2006, Canberra: Commonwealth of Australia, Australian Bureau of Statistics.
27. Smith AMA, Rissel CE, Richters J, Grulich AE, de Visser RO. Sex in Australia: the rationale and methods of the Australian Study of Health and Relationships. Australian and New Zealand Journal of Public Health 2003, 27(2):106-117. 10.1111/j.1467-842X.2003.tb00797.x, 14696700.
28. Pepin J, Labbe AC, Khonde N, Deslandes S, Alary M, Dzokoto A, Asamoah-Adu C, Meda H, Frost E. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sexually Transmissible Infections 2005, 81(1):67-72.
29. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sexually Transmitted Infections 2005, 81(6):458-462. 10.1136/sti.2004.012062, 1745067, 16326846.
30. Gomes J, Borrego M, Atik B, Santo I, Azevedo J, Brito de Sá A, Nogueira P, Dean D. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes and Infection 2006, 8(1):16-26. 10.1016/j.micinf.2005.05.014, 16289001.
31. Korte JE, Baseman JB, Cagle MP, Herrera C, Piper JM, Holden AEC, Perdue ST, Champion JD, Shain RN. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. American Journal of Reproductive Immunology 2006, 55(4):265. 10.1111/j.1600-0897.2005.00359.x, 16533338.
32. Ginige S, Chen MY, Hocking JS, Read TR, Fairley CK. Antibiotic consumption and chlamydia prevalence in international studies. Sexual health 2006, 3(4):221. 10.1071/SH06013, 17112431.
33. Bradshaw CS, Jensen JS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, Moss LM, Fairley CK. Azithromycin failure in Mycoplasma genitalium urethritis. Emerging Infectious Diseases 2006, 12(7):1149-1152.
34. Bjornelius E, Anagrius C, Bojs G, Carlberg H, Johannisson G, Johansson E, Moi H, Jensen JS, Lidbrink P. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sexually Transmitted Infections 2008, 84(1):72-76. 10.1136/sti.2007.027375, 17932127.
35. National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander People: Surveillance and Evaluation Report 2010. 2010, Sydney: National Centre in HIV Epidemiology and Clinical Research, National Centre in HIV Epidemiology and Clinical Research The University of New South Wales.
36. Batteiger B, Xu F, Johnson R, Rekart M. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. The Journal of Infectious Diseases 2010, 201:178-189. 10.1086/652400, 2934858, 20025530.
37. Smith A, Agius P, Barrett C, Mitchell A, Pitts M. Secondary students and sexual health 2008. 2009, Melbourne: Australian Research Centre in Sex, Health and Society, Latrobe University.
38. LaMontagne D, Patrick E, Fine DN, Marrazzo J. Re-evaluating selective screening criteria for Chlamydial infection among women in the U.S. Pacific Northwest. Sexually Transmitted Diseases 2004, 31(5):283-289. 10.1097/01.OLQ.0000124613.85111.6B, 15107630.
39. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR. Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States. Journal of American Medicine Association 2004, 291(18):2229-2236.
40. Low N, McCarthy A, Macleod J, Salisbury C, Horner PJ, Roberts TE, Campbell R, Herring A, Skidmore S, Sanford E, et al. The chlamydia screening studies: rationale and design. Sexually Transmitted Infections 2004, 80:342-348. 10.1136/sti.2003.006197, 1744885, 15459400.
41. Fenton K, Copas A, Mitchell K, Elam G, Carder C, Ridgway G, Wellings K, Erens B, Field J, Johnson A. The acceptibility of urinary LCR testing for Chlamydia trachomatis among participants in a probability sample survey of sexual attitudes and lifestyles. Sexually Transmitted Infections 2001, 77:194-198. 10.1136/sti.77.3.194, 1744322, 11402228.
42. Lister N, Chaves N, Pang C, Smith A, Fairley C. Clinical significance of questionnaire-elicited or clinically reported anorectal symptoms for rectal Neisseria gonorrhoea and Chlamydia trachomatis amongst men who have sex with men. Sexual Health 2008, 5:77-82. 10.1071/SH07068, 18361859.
43. Morré SA, Rozendaal L, Van Valkengoed IGM, Boeke AJP, van Voorst Vader PC, Schirm J, De Blok S, Van den Hoek JAR, Van Doornum GJJ, Meijer C. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. Journal of Clinical Microbiology 2000, 38(6):2292. 86784, 10834991.
44. Williams H, Tabrizi SN, Lee W, Kovacs GT, Garland S. Adolescence and other risk factors for Chlamydia trachomatis geniturinary infection in women in Melbourne, Australia. Sexually Transmitted Infections 2003, 79:31-34. 10.1136/sti.79.1.31, 1744610, 12576611.
45. Heal C, Jones B, Veitch C, Lamb S, Hodgens S, Browning S, Butler H, Carey M. Screening for chlamydia in general practice. Australian Family Physician 2002, 31(8):779-782.
46. Pimenta J, Catchpole M, Rogers P, Perkins E, Jackson N, Carlisle C, Randall S, Hopwood J, Hewitt G, Underhill G, et al. Opportunistic screening for genital chlamydial infection. 1: Acceptibility of urine testing in primary and secondary healthcare settings. Sexually transmitted infections 2003, 79:16-21. 10.1136/sti.79.1.16, 1744586, 12576607.
47. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Current Opinions in Infectious Diseases 2008, 21(1):65-69.